CG
BNTX icon

Cutler Group’s BioNTech BNTX Stock Holding History

Cutler Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-600
Closed -$1K – 3635
2023
Q3 		$1K Buy
+600
New +$66.4K ﹤0.01% 3430
2023
Q2 		– Sell
-600
Closed -$1K – 3595
2023
Q1 		$1K Sell
600
-1,400
-70% -$192K ﹤0.01% 3345
2022
Q4 		$16K Sell
2,000
-2,400
-55% -$369K ﹤0.01% 2368
2022
Q3 		$34K Buy
4,400
+1,400
+47% +$214K ﹤0.01% 2183
2022
Q2 		$45K Sell
3,000
-18,300
-86% -$2.8M ﹤0.01% 2014
2022
Q1 		$87K Buy
21,300
+4,900
+30% +$823K ﹤0.01% 1800
2021
Q4 		$187K Buy
16,400
+16,100
+5,367% +$4.41M 0.01% 1373
2021
Q3 		$46K Hold
300
– – ﹤0.01% 2575
2021
Q2 		$33K Sell
300
-100
-25% -$18.9K ﹤0.01% 2836
2021
Q1 		$7K Sell
400
-11,700
-97% -$1.24M ﹤0.01% 4082
2020
Q4 		$46K Sell
12,100
-8,400
-41% -$825K ﹤0.01% 2066
2020
Q3 		$91K Sell
20,500
-12,700
-38% -$911K 0.01% 1372
2020
Q2 		$496K Buy
+33,200
New +$1.66M 0.03% 495

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Cutler Group's BNTX Position: Q1 2023 in Review

Cutler Group sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 3,000 shares — an estimated $412K sold.

Cutler Group first reported a position in BNTX in Q3 2020 and held it in 10 quarters. The position peaked at $5.63M in Q1 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Cutler Group reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 3,000 BioNTech shares in Q1 2023, an estimated $412K.
  • Cutler Group first reported a position in BioNTech in Q3 2020 and held it in 10 quarters.
  • Cutler Group's BioNTech position peaked at $5.63M in Q1 2022.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.